Taken together, these findings provide new insights into the mechanism by which Psmb8 regulates Drp1 stability and subsequent cardiac I/R injury and suggest that activating Psmb8 may be a promising therapeutic strategy for ischaemic heart disease. The gene discussed is DNM1L; the disease is heart disorder.